Lavior Pharma Inc., a woman-owned pharmaceutical company developing innovative therapies for chronic and acute conditions, announced the appointment of Dr. Imaze Marian Davis, DPM, MBA, DABPM, CWSP, DABMSP, FACPM, FFPM RCPS (Glasg), as Chief Medical Officer. This strategic hire underscores the company’s commitment to clinical excellence and women’s leadership in the pharmaceutical industry.
Health Technology Insights: Oceans Healthcare Names Dr. David Rubin Chief Medical Officer
“Dr. Davis brings an extraordinary blend of clinical expertise, surgical acumen, and strategic vision,” said Anabelle Savion, Co-Founder and COO. “Her credentials in wound care and diabetic foot ulcer management—alongside board certifications in podiatric medicine, surgery, and wound healing—will be pivotal as we advance our pipeline. Appointing a distinguished woman physician as CMO reflects our values of diversity, equity, and excellence.”
“Her track record in reducing amputations through innovative protocols and her passion for mentoring future physicians align perfectly with our mission,” added Gilad Savion, CEO. “I look forward to Dr. Davis’s guidance as we accelerate clinical programs and bring new treatments to market.”
Health Technology Insights: Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences
Dr. Davis joins Lavior after nearly 20 years leading wound-care and diabetic foot initiatives—and almost two years on Lavior’s Advisory Board, where she guided clinical-trial design and protocol development. Inspired by our platform’s superior healing in chronic wounds, she embraced the CMO role.
Born in Benin City, Nigeria, Dr. Davis earned her Doctorate in Podiatric Medicine and MBA from Barry University in 2006. After completing her surgical residency at Westchester General Hospital, she became Director of the Wound Healing Center at North Shore Medical Center, turning it into a regional referral hub that significantly reduced amputation rates.
A diplomate of both the American Board of Multiple Specialties in Podiatry and the American Board of Podiatric Medicine, she holds certifications in primary care podiatric medicine, podiatric surgery, minimally invasive surgery, and is a Certified Wound Specialist Physician. She has also participated in advanced wound-care surgical training programs with North Shore Medical Center, Jackson Health System, Hialeah Hospital, and Aventura Hospital.
Elected to the ABPM Board in 2023, Dr. Davis champions the “Podiatry Forward” initiative with her colleagues to improve diabetic patient outcomes.
“I am honored to join Lavior Pharma at such an exciting time,” said Dr. Davis. “Their commitment to next-generation therapies for diabetic foot ulcers and other challenging wounds aligns with my life’s work. I look forward to collaborating across R&D, regulatory affairs, and clinical operations to bring life-changing treatments to patients.”
Health Technology Insights: Colorado Access, Innovaccer Partner to Improve Medicaid Health
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
